| Name | Title | Contact Details |
|---|---|---|
Elsa Ibarbol |
VP, Head of Global Supplier Quality | Profile |
Tina Manoharan |
Chief Technology Officer | Profile |
John McNally |
Senior Information and Product Security Officer | Profile |
Maarten Bodlaender |
Head of Cyber Security Services | Profile |
Janeine Charpiat |
Director, Product Security and Services | Profile |
Liberty Medical Supply is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
CoreMap`s goal is to improve patient outcomes by delivering advanced diagnostic technology to electrophysiologists and patients.
Esaote North America is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mabis DMI Healthcare is a Waukegan, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Modern lifestyles and persistent near vision utilization cause a majority of patients to experience the reduced visual acuity and painful symptoms of eye misalignment – headaches, eye strain, neck and shoulder pain, motion sickness and dry eye sensation. Neurolens addresses common binocular vision issues using a three-step process. Step one is efficiently identifying patient symptomology using a basic online symptom screener that every patient can complete in minutes. This information goes directly to the Neurolens Measurement Device, Gen 2—or NMD2—ready for step two, which is accurately and objectively measuring the patient`s level of misalignment. The NMD2 is an objective, accurate and repeatable way to measure eye misalignment as small as 0.01 Prism Diopters. Most importantly, step three is correcting eye misalignment with a proven lens solution. Neurolenses address binocular vision issues by providing a contoured prism lens design that gradually delivers more prism in the lens corridor from distance to near. Neurolenses are proven to have a profound impact on a patient`s visual clarity and comfort. In fact, 93% of patients responded positively to wearing Neurolenses. Over 81% of patients suffering from chronic daily headaches reported their symptoms were substantially reduced or basically gone after wearing Neurolenses for 90 days. Neurolens—recognized in 2022 as one of the 30 fastest growing private companies in the healthcare industry by Inc. Magazine—is confident that appropriately addressing growing binocular vision issues will become a standard of care in this industry, unlocking dramatic patient outcomes and practice growth.